ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients.
about
Invasive candidiasis as a cause of sepsis in the critically ill patientAntifungal agents for preventing fungal infections in non-neutropenic critically ill patientsAntimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA).Diagnosis and management of invasive candidiasis in the ICU: an updated approach to an old enemyCandida albicans Biofilms and Human DiseaseSUSCEPTIBILITY TEST FOR FUNGI: CLINICAL AND LABORATORIAL CORRELATIONS IN MEDICAL MYCOLOGYInvasive candidiasis in non neutropenic critically ill - need for region-specific management guidelinesRecurrent candida prosthetic endocarditis over fifteen years managed with medical therapy and four valvular surgeries: a case report and review of literature.Mechanisms of Candida biofilm drug resistanceHow to manage aspergillosis in non-neutropenic intensive care unit patientsTherapeutic drug monitoring for triazoles: A needs assessment review and recommendations from a Canadian perspectiveCandida colonization index and subsequent infection in critically ill surgical patients: 20 years laterRecent developments in the management of invasive fungal infections in patients with oncohematological diseasesClinical perspectives on echinocandin resistance among Candida speciesT2MR and T2Candida: novel technology for the rapid diagnosis of candidemia and invasive candidiasisEpidemiology of Blood Stream Infection due to Candida Species in a Tertiary Care Hospital in Japan over 12 Years: Importance of Peripheral Line-Associated CandidemiaEchinocandin resistance: an emerging clinical problem?Invasive candidiasis: from mycobiome to infection, therapy, and prevention.Antibiotic stewardship in the intensive care unit.Highly Dynamic and Specific Phosphatidylinositol 4,5-Bisphosphate, Septin, and Cell Wall Integrity Pathway Responses Correlate with Caspofungin Activity against Candida albicans.Fungemia in a Spanish hospital: the role of Candida parapsilosis over a 15-year period.Epidemiology and outcomes of invasive candidiasis due to non-albicans species of Candida in 2,496 patients: data from the Prospective Antifungal Therapy (PATH) registry 2004-2008.Pharmacokinetic variability and exposures of fluconazole, anidulafungin, and caspofungin in intensive care unit patients: Data from multinational Defining Antibiotic Levels in Intensive care unit (DALI) patients Study.Invasive candidiasis in intensive care unit; consensus statement from an Iranian panel of experts, July 2013Multilaboratory study of epidemiological cutoff values for detection of resistance in eight Candida species to fluconazole, posaconazole, and voriconazole.Epidemiology, species distribution and outcome of nosocomial Candida spp. bloodstream infection in ShanghaiClinical and microbiological characteristics, and impact of therapeutic strategies on the outcomes of children with candidemia.Weekly high-dose liposomal amphotericin B (L-AmB) in critically ill septic patients with multiple Candida colonization: The AmBiDex study.Invasive Candida Infections in Liver Transplant Recipients: Clinical Features and Risk Factors for Mortality.An Observational Study on Early Empiric versus Culture-Directed Antifungal Therapy in Critically Ill with Intra-Abdominal SepsisA case of Candida glabrata severe urinary sepsis successfully treated with micafunginPharmacoeconomic analysis of antifungal therapy for primary treatment of invasive candidiasis caused by Candida albicans and non-albicans Candida species.Antifungal resistance to fluconazole and echinocandins is not emerging in yeast isolates causing fungemia in a Spanish tertiary care centerWorrisome trends in incidence and mortality of candidemia in intensive care units (Paris area, 2002-2010)Prospective observational multicenter study to define a diagnostic algorithm for biliary candidiasis.DL-2-hydroxyisocaproic acid attenuates inflammatory responses in a murine Candida albicans biofilm model.Antifungal clinical trials and guidelines: what we know and do not knowSafety and efficacy of amphotericin-B deoxycholate inhalation in critically ill patients with respiratory Candida spp. colonization: a retrospective analysis.Invasive candidiasis in critical care setting, updated recommendations from "Invasive Fungal Infections-Clinical Forum", Iran.Empirical antifungal therapy with an echinocandin in critically-ill patients: prospective evaluation of a pragmatic Candida score-based strategy in one medical ICU
P2860
Q22305429-ED5532AE-AD1E-4192-9D2C-45CDC58BA15AQ24186457-21C61746-1B07-4825-BFC1-E36D25E21B5DQ26739860-8DDFF132-0797-40B5-89CA-C3FCBA78D742Q26745677-813080CE-7DA2-4FD6-B0DE-ABC8969F8C00Q26778729-FD1D5489-14DA-47A2-93A4-62C5A80EAA76Q26783197-13F8E731-6A78-4DFA-A059-305646894C26Q26801500-E1D78520-C689-47BE-8114-42FFD2F6AA2AQ26801754-593E26A1-34C4-491D-820B-8A596878DD22Q26827521-DB95562D-7308-44FB-A2C0-330AA2CCED0CQ26999448-DFC9AF5F-7BED-4311-8C78-0328F2279AA5Q27009221-DECE23C2-526F-4AD9-A28F-120E16388D5AQ27012454-857EFDAD-8EE8-48CE-988C-11FADC337B69Q28077381-7E19A08C-BE3D-4CAC-9F4B-EC1BD450EC83Q28082538-B68E4995-2B7A-49EF-B8D9-BE57958E7617Q28084998-0B35EA19-05CE-4E06-B1A5-0F9583B1D943Q28109664-830135CA-918F-485F-B45D-CE67263EE745Q28544739-04B79775-E505-4347-B3E5-A29A328ADE82Q30251428-B93F49CD-E03C-4F41-9867-DA4811BA1307Q30408712-0C91AB2D-5EA0-4EBB-B8BF-F563DCE38336Q30761249-6C088411-0954-4211-9361-AA0B6C8408C9Q30808061-3332EAC6-0814-45E1-8D4A-50BA34B3068EQ30834974-02C58CA4-0A39-4742-88B3-A1536CEA3C2DQ30936281-AFFC01C8-BD74-4DC7-B594-6176473A7823Q33576580-CBBC0BE4-45E8-4294-9C56-C36B3FAE9941Q33622915-650A9F21-C1F0-436C-B0B8-2167B68C1EBEQ33661367-8AF88B56-3DE1-4583-9881-C2728A6455C3Q33683476-111DAADE-1203-4409-AA97-FF0C6D878467Q33712955-86392E5E-774E-49B5-87D5-D5B2668E2B6FQ33719829-7D467849-BF94-4A04-BD55-17CC0CBD1CB7Q33735943-14B99383-9A9E-49AC-A307-61C7FC1C4A59Q33736871-431E4852-1AFB-498A-AB82-A23DD358EB49Q33891810-42A97800-2457-46DF-88D1-F46885A2530EQ34058322-02F7E34A-4CE2-4A11-9E3A-042D62B31828Q34100598-8C7AD889-5EF2-48AE-B382-36398EA7704DQ34168602-89471F6A-5F8B-4782-AB54-3A47CC15D865Q34260729-6CD86A7A-272F-47C2-B27E-B6FB98B4909FQ34400255-7056B58B-B6B9-46EA-9E04-2AFAB3CB0816Q34422915-7CE72BBA-AC59-45C9-B103-5941D4AA6FB8Q34452343-B6E5F162-82DC-4842-A4A0-1DB1131E4056Q34487220-9BC12753-0594-433F-9294-605BBF46FA53
P2860
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
ESCMID* guideline for the diag ...... on-neutropenic adult patients.
@en
ESCMID* guideline for the diag ...... on-neutropenic adult patients.
@nl
type
label
ESCMID* guideline for the diag ...... on-neutropenic adult patients.
@en
ESCMID* guideline for the diag ...... on-neutropenic adult patients.
@nl
prefLabel
ESCMID* guideline for the diag ...... on-neutropenic adult patients.
@en
ESCMID* guideline for the diag ...... on-neutropenic adult patients.
@nl
P2093
P50
P356
P1476
ESCMID* guideline for the diag ...... non-neutropenic adult patients
@en
P2093
A J Ullmann
B J Kullberg
C Lass-Flörl
E Castagnola
E Roilides
ESCMID Fungal Infection Study Group
G Petrikkos
P356
10.1111/1469-0691.12039
P478
18 Suppl 7
P50
P577
2012-12-01T00:00:00Z